Darifenacin 2,3-Dehydro Bromo Impurity :
5-(2-Bromoethyl)benzofuran ; C10H9BrO ; MW: 225.08 ; |
Darifenacin 3-Hydroxy Impurity :
3-Hydroxy Darifenacin ; 2-{1-[2-(2,3-Dihydro-3-hydroxy-5-benzofuranyl)ethyl]-pyrrolidin-3(S)-yl}-2,2-diphenyl-acetamide ; CAS : 206048-82-0 ; C28H30N2O3 ; MW: 442.55 |
Darifenacin 4-Hydroxy Impurity:
(S)-2-(1-(3-(2-Bromoethyl)-4-hydroxyphenethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide hydrobromide ; C28H32Br2N2O2 ; MW: 588.37 ; |
Darifenacin 5-Bromoethyl Impurity:
5-Bromoethyl-2,3-Dihydrobenzofuran ; 5-(2-Bromoethyl)-2,3-dihydrobenzofuran ; CAS : 127264-14-6 ; C10H11BrO ; MW: 227.10 ; |
Darifenacin 5-Carboxymethyl Impurity:
5-Carboxymethyl-2,3-Dihydrobenzofuran ; 2,3-Dihydro-5-benzofuranacetic acid ; CAS : 69999-16-2 ; C10H10O3 ; MW: 178.18 ; |
Darifenacin 7-Bromo Analog:
(S)-2-(1-(2-(7-Bromo-2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide ; C28H30Br2N2O2 ; MW: 586.36 ; |
Darifenacin 7-Bromoethyl Impurity:
7-(2-Bromoethyl)-2,3-dihydrobenzofuran ; C10H11BrO ; MW: 227.1 ; |
Darifenacin Carboxylic Acid Impurity :
(S)-2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetic acid hydrobromide ; C28H30BrNO3 ; MW: 508.45 ; |
Darifenacin Cyano Pyrrolidine Impurity:
(S)-3-(Cyanodiphenylmethyl)-pyrrolidine HBr ; CAS : 194602-27-2 (HBr Salt) ; 133099-11-3 (base) ; C18H19BrN2 ; Mol. Wt.: 343.26 ; |
Darifenacin Cyano t-BOC Impurity:
3-(Cyanodiphenylmethyl)-1-pyrrolidinecarboxylic acid t-butyl ester ; CAS : 1159977-31-7 ; C23H26N2O2 ; MW: 362.46 ; |
Darifenacin DBE Isomer :
(S)-2-(3-Pyrrolidinyl)-2,2-diphenyl-N-[2-(2,3-dihydrobenzfuran-5-yl)ethyl] acetamide ; C28H30N2O2 ; MW: 426.55 ; |
Darifenacin Dehydro Impurity:
(S)-2-[1-[2-(Benzfuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide HBr ; CAS : 943034-52-4 ; C28H29BrN2O2 ; MW: 505.45 ; |
Darifenacin Dimer-1 Impurity :
(S)-2-(3-Pyrrolidinyl)-2,2-diphenyl-N,N-bis[2-(2,3-dihydrobenzfuran-5-yl)ethyl]acetamide ; C38H40N2O3 ; MW: 572.74 ; |
Darifenacin Dimer-2 Impurity :
Darifenacin Impurity D ; (S)-2-[1-[2-(2,3-Dihydrobenzfuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenyl-N-[2-(2,3-dihydrobenzfuran-5-yl)ethyl]acetamide HCl ; C38H40N2O3 (base) ; MW: 572.74 ; C38H41ClN2O3 (HCl salt) ; MW: 609.20 ; |
Darifenacin HBr:
(S)-2-[1-[2-(2,3-Dihydrobenzfuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide HBr ; CAS : 133099-07-7 ; C28H31BrN2O2 ; MW: 507.46 ; |
Darifenacin N-Oxide Impurity :
(S)-2-[ 1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-1 -oxidopyrrolidin-3-yl]-2,2-diphenyl acetamide ; CAS : 1391080-40-2 ; C28H30N2O3 ; MW: 442.55 ; |
Darifenacin Nitrile Impurity :
Darifenacin Impurity C ; (3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidine acetonitrile HCl ; CAS : 252317-48-9 (base) ; C28H28N2O (base) ; MW: 408.53 ; C28H29ClN2O (HCl salt) ; MW: 445.00 ; |
Darifenacin Pyrrolidin Carboxylic Acid Impurity:
(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetic acid ; C18H19NO2 ; MW: 281.35 ; |
Darifenacin Pyrrolidine Impurity (S)-Isomer:
(S)-2-(3-Pyrrolidinyl)-2,2-diphenylacetamide L-tartrate ; CAS : 134002-26-9 ; C22H26N2O7 ; MW: 430.45 ; |
Darifenacin Pyrrolidine Impurity Racemate :
2-(3-Pyrrolidinyl)-2,2-diphenylacetamide ;CAS : 103887-32-7 ; C18H20N2O ; MW: 280.36 ; |
Darifenacin Pyrrolidinium Dimer Impurity :
(3S)-3-(2-Amino-2-oxo-1,1-diphenylethyl)-1,1-bis[2-(2,3-dihydro-5-benzofuranyl)ethyl]pyrrolidinium Bromide ; CAS : 1396968-57-2 ; C38H41BrN2O3 ; MW: 653.65 ; |
Darifenacin R-Isomer :
(R)-2-[1-[2-(2,3-Dihydrobenzfuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide HBr ; C28H31BrN2O2 ; MW: 507.46 ; |
Darifenacin Vinyl Impurity :
5-Vinylbenzofuran ; C10H8O ; MW: 144.17 ; |